Literature DB >> 17211622

Multi drug resistance-dependent "vacuum cleaner" functionality potentially driven by the interactions between endocytosis, drug size and Pgp-like transporters surface density.

Cyril Rauch1, Alain Pluen.   

Abstract

In cells, multi drug resistance (MDR) is associated with Pgp-like transporters expression extruding drugs from cellular membranes. MDR is efficiently generated with a relatively small fraction of membrane transporters. As the insertion of drugs into cellular membranes is widespread, there are no reasons why a drug should incorporate the membrane in the vicinity of a transporter. As a result a further elusive hypothesis is usually invoked: these transporters act like "vacuum cleaners" of drugs embedded in the membrane. Nonetheless, how these transporters attract drugs remains obscure. To clarify the "vacuum cleaner" notion, we suggest that during its residency time in cellular membranes, the lateral movement of drugs from their point of insertion to transporters is governed by Brownian's diffusion, which allows the drugs/transporters interaction. Taking into account the functionality of Pgp-like transporters, namely the extrusion of drugs from the plasma membrane inner leaflet, we characterize how the state of drug resistance is triggered involving: membrane endocytosis, drug physico-chemical properties and the surface density of Pgp-like transporters. In addition, the theory developed provides for the first time a theoretical proof of Lipinski's second rule with regard to drugs' size (or MW) selectivity on their permeation across cellular membranes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17211622     DOI: 10.1007/s00249-006-0113-3

Source DB:  PubMed          Journal:  Eur Biophys J        ISSN: 0175-7571            Impact factor:   2.095


  55 in total

1.  Endocytosis switch controlled by transmembrane osmotic pressure and phospholipid number asymmetry.

Authors:  C Rauch; E Farge
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

Review 2.  Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane.

Authors:  J Ferté
Journal:  Eur J Biochem       Date:  2000-01

3.  Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity.

Authors:  P K Dudeja; K M Anderson; J S Harris; L Buckingham; J S Coon
Journal:  Arch Biochem Biophys       Date:  1995-05-10       Impact factor: 4.013

4.  Analysis of drug transport kinetics in multidrug-resistant cells using a novel coumarin-vinblastine compound.

Authors:  W G Bornmann; P D Roepe
Journal:  Biochemistry       Date:  1994-10-25       Impact factor: 3.162

5.  Permeability of lipid bilayer to anthracycline derivatives. Role of the bilayer composition and of the temperature.

Authors:  F Frézard; A Garnier-Suillerot
Journal:  Biochim Biophys Acta       Date:  1998-01-05

6.  Transport of anthracyclines and mitoxantrone across membranes by a flip-flop mechanism.

Authors:  Ronit Regev; Daniella Yeheskely-Hayon; Hagar Katzir; Gera D Eytan
Journal:  Biochem Pharmacol       Date:  2005-07-01       Impact factor: 5.858

7.  A novel areneisonitrile Tc complex inhibits the transport activity of MDR P-glycoprotein.

Authors:  V V Rao; L W Herman; J F Kronauge; D Piwnica-Worms
Journal:  Nucl Med Biol       Date:  1998-04       Impact factor: 2.408

8.  Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells.

Authors:  J M Zamora; H L Pearce; W T Beck
Journal:  Mol Pharmacol       Date:  1988-04       Impact factor: 4.436

9.  Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells.

Authors:  R Regev; Y G Assaraf; G D Eytan
Journal:  Eur J Biochem       Date:  1999-01

10.  Defective acidification in human breast tumor cells and implications for chemotherapy.

Authors:  N Altan; Y Chen; M Schindler; S M Simon
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

View more
  10 in total

1.  On the relationship between drug's size, cell membrane mechanical properties and high levels of multi drug resistance: a comparison to published data.

Authors:  Cyril Rauch
Journal:  Eur Biophys J       Date:  2008-12-10       Impact factor: 1.733

Review 2.  On a biophysical and mathematical model of Pgp-mediated multidrug resistance: understanding the "space-time" dimension of MDR.

Authors:  Vasiliki Panagiotopoulou; Giles Richardson; Oliver E Jensen; Cyril Rauch
Journal:  Eur Biophys J       Date:  2009-11-04       Impact factor: 1.733

Review 3.  Toward a mechanical control of drug delivery. On the relationship between Lipinski's 2nd rule and cytosolic pH changes in doxorubicin resistance levels in cancer cells: a comparison to published data.

Authors:  Cyril Rauch
Journal:  Eur Biophys J       Date:  2009-03-19       Impact factor: 1.733

4.  Proton dynamics in cancer.

Authors:  Veronica Huber; Angelo De Milito; Salvador Harguindey; Stephan J Reshkin; Miriam L Wahl; Cyril Rauch; Antonio Chiesi; Jacques Pouysségur; Robert A Gatenby; Licia Rivoltini; Stefano Fais
Journal:  J Transl Med       Date:  2010-06-15       Impact factor: 5.531

5.  Importance of the difference in surface pressures of the cell membrane in doxorubicin resistant cells that do not express Pgp and ABCG2.

Authors:  Charlotte Bell; Claire Hill; Christopher Burton; Adam Blanchard; Freya Shephard; Cyril Rauch
Journal:  Cell Biochem Biophys       Date:  2013-07       Impact factor: 2.194

6.  Dual role of nanoparticles as drug carrier and drug.

Authors:  Hirak Kumar Patra; Anjan Kr Dasgupta; Sounik Sarkar; Indranil Biswas; Arnab Chattopadhyay
Journal:  Cancer Nanotechnol       Date:  2011-01-01

Review 7.  Acid-mediated Lipinski's second rule: application to drug design and targeting in cancer.

Authors:  Ziad Omran; Cyril Rauch
Journal:  Eur Biophys J       Date:  2014-04-01       Impact factor: 1.733

8.  Proposed lead molecules against Hemagglutinin of avian influenza virus (H5N1).

Authors:  Tannistha Nandi
Journal:  Bioinformation       Date:  2008-01-27

Review 9.  Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs--an integral molecular/biochemical/metabolic/clinical approach after one hundred years of cancer research.

Authors:  Salvador Harguindey; Jose Luis Arranz; Julian David Polo Orozco; Cyril Rauch; Stefano Fais; Rosa Angela Cardone; Stephan J Reshkin
Journal:  J Transl Med       Date:  2013-11-06       Impact factor: 5.531

10.  Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance.

Authors:  Sofia Avnet; Silvia Lemma; Margherita Cortini; Paola Pellegrini; Francesca Perut; Nicoletta Zini; Katsuyuki Kusuzaki; Tokuhiro Chano; Giulia Grisendi; Massimo Dominici; Angelo De Milito; Nicola Baldini
Journal:  Oncotarget       Date:  2016-09-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.